Medicare billing address
CMS Medicare provider billing file
137 Lankenau Medical Building WWynnewood, PA 19096
CMS public data · NPI 1083810048
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Hyon Ju Park, MD
Specialty
Credential
MD
NPI
1083810048
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Hyon Ju Park, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
137 Lankenau Medical Building WCMS Doctors & Clinicians file
825 Old Lancaster RdIn the 2024 CMS provider billing file, this NPI had 298 Medicare beneficiaries and 67,038 total services. The average beneficiary age was 74, and the average HCC risk score was 1.3.
Total Medicare allowed amount
$838,838.81
Total Medicare payment amount
$661,903.10
Medicare beneficiaries
298
Total services
67,038
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
68%
CMS beneficiary-panel share
Osteoporosis
55%
CMS beneficiary-panel share
Ischemic heart disease
35%
CMS beneficiary-panel share
Mood disorders
29%
CMS beneficiary-panel share
Anxiety
27%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 23,600 | $4.56 |
| Injection, romosozumab-aqqg, 1 mg | 13,230 | $10.81 |
| Injection, denosumab, 1 mg | 7,320 | $25.69 |
| Injection, methylprednisolone acetate, 1 mg | 1,401 | $0.13 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 373 | $130.57 |
| Injection of drug or substance under skin or into muscle | 247 | $14.69 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 167 | $0.95 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 116 | $73.97 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 108 | $93.33 |
| Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 86 | $183.52 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1083810048. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Prednisone | Prednisone | 254 | 338.5 | $1,559.16 |
| 2 | Alendronate Sodium | Alendronate Sodium | 86 | 180.2 | $777.19 |
| 3 | Methotrexate | Methotrexate Sodium | 82 | 226.3 | $2,958.20 |
| 4 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 61 | 168 | $3,100.78 |
| 5 | Humira(Cf) Pen | Adalimumab | 56 | 69.3 | $500,967.15 |
| 6 | Duloxetine Hcl | Duloxetine Hcl | 55 | 121 | $1,602.34 |
| 7 | Allopurinol | Allopurinol | 45 | 117.7 | $551.66 |
| 8 | Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 33 | 43 | $99.52 |
| 9 | Leflunomide | Leflunomide | 31 | 82.5 | $1,464.06 |
| 10 | Tramadol Hcl | Tramadol Hcl | 29 | 29 | $192.88 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Icahn School Of Medicine At Mount Sinai
Graduation year
2007
Group/practice field
Bryn Mawr Medical Specialists Association
Telehealth reported
Yes
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.